Downregulation of the Expression of the Main Immunoglobulin VH Family in HIV-Infected Patients: Modulation by Triple Combination Therapy
Authors:
- Denis DavidDDDenis David
- Rene PiresRPRene Pires
- Marie-Pierre TreilhouMTMarie-Pierre Treilhou
- Bertrand DupontBDBertrand Dupont
- Marcel JoussemetMJMarcel Joussemet
- Gilles PialouxGPGilles Pialoux
- Jacques ThezeJTJacques Theze
- Jean-Pierre BouvetJBJean-Pierre Bouvet
- 10 February 1999
- journal article
- research article
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 15 (3) , 315-316
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Regulatory dysfunction of the interleukin-2 receptor during HIV infection and the impact of triple combination therapyProceedings of the National Academy of Sciences, 1998
- Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferationNature Medicine, 1998
- B-cell superantigensImmunology Today, 1997
- B Cell Superantigens: Potential Modifiers of the Normal Human BCell RepertoireInternational Reviews of Immunology, 1997
- BCell Superantigens in HIV-1 InfectionInternational Reviews of Immunology, 1997
- HIV-1gp120: A Novel Viral B Cell SuperantigenInternational Reviews of Immunology, 1997
- Progressive decrease in VH3 gene family expression in plasma cells of HIV-infected patientsInternational Immunology, 1996
- Characteristics of human antibody repertoires following active immune responses in vivoMolecular Immunology, 1996
- B-cell superantigens: implications for selection of the human antibody repertoireImmunology Today, 1995
- B‐Cell Abnormalities in AIDS: Stable and Clonally‐Restricted Antibody Response in HIV‐1 InfectionScandinavian Journal of Immunology, 1993